Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | GFER | P55789 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | NGLY1 | Q96IV0 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8006518 | 1.00 | IDO1 (1.00) | IDO1KDM4EALDH1A1HPGDGFER | |
| SCHEMBL29475880 | 1.00 | IDO1 (1.00) | IDO1KDM4EALDH1A1HPGDGFER | |
| Questiomycin B SCHEMBL8006530 | 0.89 | IDO1 (0.79) | IDO1KDM4EALDH1A1HPGDGFER | |
| SCHEMBL7592067 | 0.86 | IDO1 (0.74) | IDO1KDM4EALDH1A1HPGDGFER | |
| SCHEMBL15133540 | 0.86 | IDO1 (0.75) | IDO1KDM4EALDH1A1HPGDGFER | |
| 3-Aminophenol SCHEMBL7991041 | 0.85 | IDO1 (0.72) | IDO1KDM4EALDH1A1HPGDGFER | |
| SCHEMBL22328876 | 0.84 | IDO1 (0.71) | IDO1KDM4EALDH1A1HPGDGFER | |
| SCHEMBL14503721 | 0.84 | IDO1 (0.71) | IDO1KDM4EALDH1A1HPGDGFER | |
| SCHEMBL69178 | 0.84 | IDO1 (0.71) | IDO1KDM4EALDH1A1HPGDGFER | |
| SCHEMBL29373760 | 0.84 | IDO1 (0.71) | IDO1KDM4EALDH1A1HPGDGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1996 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| CN-119781246-A | Photosensitive polyimide resin composition, cured film, and preparation method and application thereof | 吉林奥来德光电材料股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| WO-2024190663-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| CN-118637984-A | Synthesis method of (4-chloro-naphthalene-2-yl) -methanol | 埃法姆(常州)生命科学技术有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-117416983-A | Naphthoxyhc acid and/or its derivative acid radical intercalation hydrotalcite-like compound and its preparation method | 中国科学院青海盐湖研究所 | 2024-01-19 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| WO-2023014909-A1 | AMPHIPHILIC PEPTIDES FOR NUCLEIC ACID AND PROTEIN DELIVERY | AJK Biopharmaceutical, LLC (US) | 2023-02-09 | — | — | WO | claimed |
| US-20230000999-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY | PARANG KEYKAVOUS (US) | 2023-01-05 | — | — | US | claimed |
| CN-115244067-A | Synthetic antimicrobial peptides | AJK生物制药有限责任公司 | 2022-10-25 | — | — | CN | claimed |
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | AJK BIOPHARMACEUTICAL LLC (US) | 2022-09-15 | — | — | US | claimed |
| EP-0820759-A2 | Compositions for dyeing keratinous fibers | Henkel Kommanditgesellschaft auf Aktien (DE) | 1998-01-28 | — | — | EP | claimed |
| EP-0515379-A4 | ELECTRO-BLOTTING OF ELECTROPHORETICALLY RESOLVED FLUORESCENT-LABELED SACCHARIDES AND DETECTION OF ACTIVE STRUCTURES WITH PROTEIN PROBES | GLYCOMED INC (US) | 1994-09-14 | — | — | EP | claimed |
| EP-0515379-A1 | ELECTRO-BLOTTING OF ELECTROPHORETICALLY RESOLVED FLUORESCENT-LABELED SACCHARIDES AND DETECTION OF ACTIVE STRUCTURES WITH PROTEIN PROBES | GLYCOMED INCORPORATED (US) | 1992-12-02 | — | — | EP | claimed |
| US-5094740-A | TWO-DIMENSIONAL ELECTROPHORETIC SEPARATION OF CARBOHYDRATES | GLYCOMED, INC. (US) | 1992-03-10 | — | — | US | claimed |
| WO-1991012275-A1 | TWO-DIMENSIONAL ELECTROPHORETIC SEPARATION OF CARBOHYDRATES | GLYCOMED INCORPORATED (US) | 1991-08-22 | — | — | WO | claimed |
| WO-1991012276-A1 | ELECTRO-BLOTTING OF ELECTROPHORETICALLY RESOLVED FLUORESCENT-LABELED SACCHARIDES AND DETECTION OF ACTIVE STRUCTURES WITH PROTEIN PROBES | GLYCOMED INCORPORATED (US) | 1991-08-22 | — | — | WO | claimed |
| US-4996339-A | Colorless | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 1991-02-26 | — | — | US | claimed |
| US-4855208-A | Toner for developing electrostatic latent images | ORIENT CHEMICAL INDUSTRIES LTD. (JP) | 1989-08-08 | — | — | US | claimed |
| EP-0210751-A2 | Halogen-containing rubbers and their manufacture | MARINE MAGNESIUM COMPANY (US) | 1987-02-04 | — | — | EP | claimed |
| US-4632954-A | WITH AMINOCARBOXY COMPOUNDS | CALGON CORPORATION (US) | 1986-12-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230000999-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY | ARGLU1, SLC7A11, PNISR | IDO1 416/4885KDM4E 4432/4885ALDH1A1 4266/4885 |
| US-20220289794-A1 | SYNTHETIC ANTIMICROBIAL PEPTIDES | VIP, HM13, NGLY1 | IDO1 1485/4885KDM4E 3892/4885ALDH1A1 4873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.